10mg / Vial Pharmaceutical Peptides Purity 99% Muscle Growth Peptides Cas 10813-74-8

Newly bodybuilding peptides and human growth hormone peptide,purity 99% muscle growth peptides

    Growth hormone-releasing peptide 6 (GHRP-6) (developmental code name SKF-110679), also known as growth hormone-releasing hexapeptide, is one of several synthetic met-enkephalin analogues that include unnatural D-amino acids, were developed for their growth hormone-releasing activity and are called growth hormone secretagogues. They lack opioid activity but are potent stimulators of growth hormone (GH) release. These secretagogues are distinct from growth hormone releasing hormone (GHRH) in that they share no sequence relation and derive their function through activation of a completely different receptor. This receptor was originally called the growth hormone secretagogue receptor (GHSR), but due to subsequent discoveries, the hormone ghrelin is now considered the receptor's natural endogenous ligand, and it has been renamed as the ghrelin receptor. Therefore, these GHSR agonists act as synthetic ghrelin mimetics.

    It has been discovered that when GHRP-6 and insulin are administered simultaneously, GH response to GHRP-6 is increased (1). However, the consumption of carbohydrates and/or dietary fats, around the administration window of GH secretagogues significantly blunts the GH release. A recent study in normal mice showed significant differences in body composition, muscle growth, glucose metabolism, memory and cardiac function in the mice being administered the GHRP-6 (2). There are still many questions regarding this fairly new compound.

    Despite intense basic research and numerous novel therapies under clinical investigation, cardioprotection as principal pharmacological indication remains as an empty niche. We have rigorously reviewed the investigational development of growth hormone releasing peptides (GHRP) and their clinical niching perspectives. GHRP constitute a group of small synthetic peptides that stimulate the growth hormone secretion and downstream axis activity. Two well-characterized peptidyl secretagogues receptors (GHSR 1a and CD36) are broadly represented including the cardiovascular system. Early studies translated into a new research era that inserted synthetic GHRP as promising cardio and cytoprotective candidates. A broad safety profile and a successful preclinical pharmacology nurtured the enthusiasm before one of these GHRP family members (GHRP-6) as a myocardial reperfusion damages-attenuating candidate. The existence of efficacious although occasional and fragmented clinical interventions in life-threatening conditions, along with the GHRP-6 multifactorial mechanism of action in myocardial infarction, ignite the initiative for a coherent clinical development.

Q1:Do you Accept Sample Order?
A: Yes, we accept small order from 1box, 5boxes and 10boxes to evaluate quality of our goods.

Q2: Is there any discount?
A: Yes, as for old customers and larger quantity, we always support with great discounts and surprise.

Q3: How to make the payment?

A: a Let me know the item, quantity and the destination country

b After you confirm all details of order, pay money and give us Shipping address.

c We can accept , Money Gram and Paypal as well.

dWe arrange the shipment at first time after receive payment and give you the tracking number

e We will supply after-sales service after you receive parcel.

Q4:How will you deliver the goods?

A: We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS, China Air Post, HongKong Air Post. And you also can choose your own shipping forwarder.Usually it takes about 5-12 working days to reach you.

Q5:What are your packing ?

We use standard packaging to ensure that the goods will be safely passed through customs and reach your hands

Q6: How do you treat quality complaint?
A: Our QC department will do strict examination of our export products by HPLC, UV, GC , TLC and so on.. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.